Positive results from the aleniglipron Phase 2 ACCESS programs in December 2025 demonstrated significant weight loss across all doses and up to 15.3% at 36 weeks Topline 44-week data from the ACCESS ...
The CRN 2026 Partner Program Guide includes software vendor partner programs that are designated 5-Star programs.
An independent informational overview of MEDVi's compounded tirzepatide telehealth program, including regulatory ...
The CRN 2026 Partner Program Guide includes computing IT vendor partner programs that are designated 5-Star programs.
A global certification pathway validates NoSQL expertise through secure testing and digital credentials aligned with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results